13 Apr2026IDEAYA’s eye cancer drug combination achieves the primary endpoint in a mid-to-late-stage trialAuthor Team HF Posted on April 13, 2026April 13, 2026IDEAYA Biosciences said on Monday that its drug for a type of eye cancer me...
13 Apr2026GSK sees blockbuster potential in its targeted cancer therapy following promising early-stage dataAuthor Team HF Posted on April 13, 2026April 13, 2026British drugmaker GSK’s experimental targeted cancer drug Mo-rez has bloc...
13 Apr2026PolyPeptide draws takeover interest from EQT and KKRAuthor Team HF Posted on April 13, 2026April 13, 2026Swiss contract drug manufacturer PolyPeptide Group AG has reportedly drawn...
10 Apr2026Amgen’s lung cancer drug tarlatamab receives approval in ChinaAuthor Team HF Posted on April 10, 2026April 10, 2026Amgen’s lung cancer drug tarlatamab has received approval from China’s...
10 Apr2026U.S. fertility rate falls to record low in 2025 as number of births declinesAuthor Team HF Posted on April 10, 2026April 10, 2026Provisional data from the Centers for Disease Control and Prevention releas...